{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:34:40Z","timestamp":1773380080986,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002342","name":"Suomalainen Tiedeakatemia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Adenosine deaminases (ADAs) are enzymes of purine metabolism converting adenosine to inosine. There are two types of ADAs in humans ADA1 and ADA2. While both ADA1 and ADA2 share the same substrate, they differ in expression, cellular localization, and catalytic properties. The genetic deficiency of ADA1 results in severe combined immunodeficiency (SCID), while lack in ADA2 (DADA2) results in multiple phenotypes ranging from systemic inflammation to vascular pathology. Clinical studies have shown that the levels of ADAs in biological fluids are altered in pathophysiological conditions, suggesting that ADA activity could be a convenient marker for the diagnosis of immune diseases and cancer. Here, we describe sensitive and straightforward ELISA assays to measure ADA1 and ADA2 concentrations in biological fluids. Analysis of the serum and saliva samples from the healthy controls and DADA2 patients revealed that ADA2 enzyme concentration is significantly lower in patients than in healthy controls. In contrast, the concentration of ADA2 increases in the serum of patients with large granular leukocyte leukemia (LGLL) and patients\u2019 saliva with head and neck cancer. Thus, this simple, non-invasive method allows for distinguishing healthy controls from the affected patient. It can be implemented in screening and diagnosis of DADA2 and follow up the treatment of LGLL and several types of head and neck cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2022.928438","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T09:58:14Z","timestamp":1659002294000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenwen","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey V.","family":"Zavialov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2174\/138945012800564095","article-title":"Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders","volume":"13","author":"Antonioli","year":"2012","journal-title":"Curr Drug targets"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.70.6.920","article-title":"Cytokines regulate membrane adenosine deaminase on human activated lymphocytes","volume":"70","author":"Cordero","year":"2001","journal-title":"J Leukoc Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1109764","article-title":"Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages","volume":"88","author":"Zavialov","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1559-0275-11-9","article-title":"Glycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasma","volume":"11","author":"Yang","year":"2014","journal-title":"Clin proteomics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.5.626-630.1995","article-title":"Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections","volume":"2","author":"Tsuboi","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20050683","article-title":"Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity","volume":"391","author":"Zavialov Andrey","year":"2005","journal-title":"Biochem J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"New Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00918-8","article-title":"Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)","volume":"44","author":"Lee","year":"2022","journal-title":"Semin immunopathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"New Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-009-9165-3","article-title":"Tuberculous pleural effusion","volume":"187","author":"Porcel","year":"2009","journal-title":"Lung"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21836","article-title":"Serum adenosine deaminase (ADA) activity: A novel screening test to differentiate HIV monoinfection from HIV-HBV and HIV-HCV coinfections","volume":"30","author":"Abdi","year":"2016","journal-title":"J Clin Lab anal"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.09.006","article-title":"Plasma adenosine deaminase activity among HIV1 clade c seropositives: relation to CD4 T cell population and antiretroviral therapy","volume":"377","author":"Chittiprol","year":"2007","journal-title":"Clin chim acta; Int J Clin Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.725447","article-title":"Serum biomarker profile including CCL1, CXCL10, VEGF, and adenosine deaminase activity distinguishes active from remotely acquired latent tuberculosis","volume":"12","author":"Delemarre","year":"2021","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s100670170005","article-title":"Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus","volume":"20","author":"Hitoglou","year":"2001","journal-title":"Clin Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216030","article-title":"Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"79","author":"Lee","year":"2020","journal-title":"Ann rheumatic diseases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.11.028","article-title":"Serum activity of macrophage-derived adenosine deaminase 2 is associated with liver fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Jiang","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2009.10.012","article-title":"Diagnostic value of adenosine deaminase activity in benign and malignant breast tumors","volume":"41","author":"Aghaei","year":"2010","journal-title":"Arch Med Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2279-5","article-title":"Adenosine deaminase activity in patients with ovarian neoplasms","volume":"286","author":"Urunsak","year":"2012","journal-title":"Arch gynecol obstetrics"},{"key":"B21","first-page":"58","article-title":"Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-alpha (TNFalpha) concentration in chronic heart failure","volume":"13","author":"Khodadadi","year":"2014","journal-title":"EXCLI J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0340","article-title":"Targeting adenosine with adenosine deaminase 2 to inhibit growth of solid tumors","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/09674845.2012.11669915","article-title":"Plasma adenosine deaminase isoform 2 in cancer patients undergoing chemotherapy","volume":"69","author":"Roberts","year":"2012","journal-title":"Br J BioMed Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2021-0324","article-title":"Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection","volume":"59","author":"Franco-Martinez","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2357-0","article-title":"Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells","volume":"74","author":"Kaljas","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"31370","DOI":"10.1038\/srep31370","article-title":"Application of ADA1 as a new marker enzyme in sandwich ELISA to study the effect of adenosine on activated monocytes","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.01.012","article-title":"ADA2 deficiency: Clonal lymphoproliferation in a subset of patients","volume":"141","author":"Trotta","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1635","article-title":"Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa","volume":"151","author":"Gonzalez Santiago","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506","article-title":"Mutant ADA2 in vasculopathies","volume":"371","author":"van Montfrans","year":"2014","journal-title":"New Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"108525","DOI":"10.1016\/j.clim.2020.108525","article-title":"Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations","volume":"218","author":"Saettini","year":"2020","journal-title":"Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2005.01131.x","article-title":"Adenosine deaminase and 5'-nucleotidase activities in saliva from patients with oral and laryngeal cancer","volume":"11","author":"Saracoglu","year":"2005","journal-title":"Oral diseases"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2010.03.011","article-title":"Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients","volume":"21","author":"Porcel","year":"2010","journal-title":"Eur J Internal Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.05.020","article-title":"Analysis of serum adenosine deaminase (ADA) and ADA1 and ADA2 isoenzyme activities in HIV positive and HIV-HBV co-infected patients","volume":"44","author":"Khodadadi","year":"2011","journal-title":"Clin Biochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-010-0404-z","article-title":"Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue","volume":"15","author":"Rai","year":"2010","journal-title":"Clin Oral Investig"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.928438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T09:58:19Z","timestamp":1659002299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.928438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2022.928438"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.928438","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"article-number":"928438"}}